Based on 4 analysts giving stock ratings to Plus Therapeutics Inc in the past month.
In the current month, PSTV has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PSTV average Analyst price target in the last month is 27.750.
Based on analysts' estimates, PSTV EPS is projected to reach -0.890 in FY2026Q4, following reported EPS of -1.144 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -1.14, while Plus Therapeutics IncPSTV's earnings per share (EPS) for the previous quarter was USD -1.31. EPS for the next quarter is expected at USD -0.89.